"label","name","uuid:ID","text","id","instanceType","description"
"","OBJ1","c36bb687-ffa0-4bff-a815-fd878effeb88","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1","Objective","Main objective"
"","OBJ2","a3813cd6-bdea-4061-8406-40063bf12375","To document the safety profile of the xanomeline TTS.","Objective_2","Objective","Safety"
"","OBJ3","6983f316-923e-421e-a3a0-caee746134d9","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3","Objective","Behaviour"
